The global minimally invasive gastrointestinal surgical systems market will grow at a 6.7% CAGR during 2021-2027 owing to the availability of technologically developed products in the field of GI surgical procedures, rising cases of GI disorders, increased benefits of minimally invasive surgeries over conventional open surgeries, rising healthcare expenditure, and increase in the healthcare outcomes will drive the growth of the minimally invasive gastrointestinal surgical systems market. Furthermore, the adoption of robotics in GI surgical procedures will dr4ive the growth of the minimally invasive gastrointestinal surgical systems market.

Nevertheless, the increasing public-private initiatives to enhance research activities on minimally invasive surgical instruments, development of long-distance teleoperated surgical robotic systems, M&A to expand the endoscopic portfolio, growing investment for regional expansions, and growing R&D activities will fuel the growth of the minimally invasive gastrointestinal surgical systems market.

The COVID-19 outbreak has had a negative impact on the economy and public health. There is a need to have robotic assistance in the minimally invasive gastrointestinal surgical systems market post-COVID-19 pandemic for effective treatment.

Request to get a free sample copy at https://www.vynzresearch.com/healthcare/minimally-invasive-gastrointestinal-surgical-systems-market/request-sample

Based on surgery, the appendectomy is anticipated to grow at a significant pace owing to the rising prominence of appendicitis globally which has been prevalent in developed countries. The increased awareness and fast adoption of diagnostic techniques for appendicitis will further propel the growth of the minimally invasive gastrointestinal surgical systems market.

FUJIFILM Healthcare Americas Corporation has launched the El740D / S dual-channel endoscope in October 2021. It is the first dual-channel endoscope approved for use in the upper and lower gastrointestinal tracts by the US Food and Drug Administration (FDA). It offers excellent image quality and has dual-channel diameters of 3.7mm and 3.2mm, so it can be used with a variety of endoscopic devices.

Asia-Pacific is anticipated to have the fastest growth in the minimally invasive gastrointestinal surgical systems market owing to more adaptive and business-friendly regulatory policies in the developing economies. Moreover, the increased competition in mature markets has allowed the industry players in the minimally invasive gastrointestinal surgical systems market to focus on underdeveloped countries.

The prominent players in the minimally invasive gastrointestinal surgical system industry include Olympus Corporation, B. Braun Melsungen AG, Karl Storz SE & Co. KG, FUJIFILM Holdings Corporation, Ambu A/S, Medtronic, Intuitive Surgical, Stryker, Asensus Surgical US, Inc., and Xenocor, Inc.

Source: VynZ Research